The following government grants in the FederalGrants.com database contain the term National Institutes of Health in the listing.
Grants are sorted newest to oldest. Select a grant title to view the complete details, including information on who to contact and how to apply.
| Grant Title | CFDA | Funding Number |
| Opportunity RFA-OD-09-008 |
93.701 |
RFA-OD-09-008 |
| Opportunity RFA-AI-09-040 |
93.701 |
RFA-AI-09-040 |
| Dissecting the Early HIV Immune Response: A Systems Biology Approach (P01) |
93.855 |
RFA-AI-09-018 |
| SBIR E-learning for HAZMAT and Emergency Response (SBIR [R43/R44]) |
93.142 |
RFA-ES-09-006 |
| The National Drug Abuse Treatment Clinical Trials Network (U10) |
93.279 |
RFA-DA-10-009 |
| Identifying Non-coding RNA Targets for Cancer Early Detection and Prevention (R21) |
93.393 |
PA-09-200 |
| Identifying Non-coding RNA Targets for Cancer Early Detection and Prevention (R01) |
93.393 |
PA-09-199 |
| Biomarkers for Early Detection of Hematopoietic Malignancies (R21) |
93.393 |
PA-09-198 |
| Biomarkers for Early Detection of Hematopoietic Malignancies (R01) |
93.393 |
PA-09-197 |
| Safe and Effective Instruments and Devices for use in the Neonatal Intensive Care Units (STTR [R41]) |
93.838 |
RFA-HD-09-018 |
| Safe and Effective Instruments and Devices for use in the Neonatal Intensive Care Units (SBIR [R43]) |
93.173 |
RFA-HD-09-017 |
| Cancer Nanotechnology Platform Partnerships (U01) |
93.393 |
RFA-CA-09-013 |
| Centers of Cancer Nanotechnology Excellence (CCNEs)(U54) |
93.393 |
RFA-CA-09-012 |
| International Research Collaborations on HIV/AIDS and Drug Use (R01) |
93.279 |
RFA-DA-10-008 |
| Mechanisms, Measurement, and Management of Pain in Aging: from Molecular to Clinical (R03) |
93.866 |
PA-09-195 |
| Ancillary Studies of Acute Kidney Injury, Chronic Kidney Disease, and End Stage Renal Disease Accessing Information from Clinical Trials, Epidemiological Studies, and Databases (R01) |
93.837 |
PA-09-196 |
| Mechanisms, Measurement, and Management of Pain in Aging: from Molecular to Clinical (R21) |
93.866 |
PA-09-194 |
| Integrating Translational Neuroscience and Adolescent Drug Abuse Treatment (R21) |
93.279 |
RFA-DA-10-003 |
| Mechanisms, Measurement, and Management of Pain in Aging: from Molecular to Clinical (R01) |
93.213 |
PA-09-193 |
| Pilot-Scale Libraries (PSL) for High-Throughput Screening (P41) |
93.310 |
RFA-RM-09-007 |
| Basic HIV Vaccine Discovery Research (R01) |
93.855 |
RFA-AI-09-024 |
| Technology Development for the Detection and Evaluation of Chemical and Biological Carcinogens (SBIR) [R43/R44] |
93.396 |
PA-09-187 |
| Technology for the Detection and Characterization of Low Abundance Proteins, Peptides, or micro RNAs (SBIR) [R43/R44] |
93.242 |
PA-09-189 |
| Technologies and Software to Support Integrative Cancer Biology Research (SBIR) [R43/R44] |
93.396 |
PA-09-188 |
| Collaborative Minority Alcohol Research Center Development (U54) |
93.891 |
RFA-AA-10-001 |
| Opportunity PA-09-186 |
93.173 |
PA-09-186 |
| Translational Programs in Lung Diseases (P01) |
93.838 |
PAR-09-185 |
| PSI:Biology Knowledgebase (U01) |
93.859 |
RFA-GM-10-004 |
| Paul D. Wellstone Muscular Dystrophy Cooperative Research Centers (U54) |
93.837 |
RFA-HD-09-027 |
| Recovery Act Limited Competition: NCMHD Exploratory Centers of Excellence (P20) |
93.701 |
RFA-MD-09-007 |
| Recovery Act Limited Competition: NCMHD Dissertation Research Award to Increase Diversity (R36) |
93.701 |
RFA-MD-09-008 |
| Recovery Act Limited Competition: NCMHD Community Participation in Health Disparities Intervention Research Planning Phase (R24) |
93.701 |
RFA-MD-09-006 |
| NIDCR Small Research Grants for Data Analysis and Statistical Methodology (R03) |
93.121 |
PAR-09-182 |
| Community Clinical Oncology Program (U10) |
93.399 |
RFA-CA-09-022 |
| Non-Invasive Methods for Diagnosis and Progression of Diabetes, Kidney, Urological, Hematological and Digestive Diseases and Hypertensive Disorders (R01) |
93.837 |
PA-09-181 |
| Noninvasive Assays of Human Oocytes and Preimplantation Embryos (STTR [R41]) |
93.865 |
RFA-HD-09-024 |
| Noninvasive Assays of Human Oocytes and Preimplantation Embryos (SBIR [R43]) |
93.865 |
RFA-HD-09-025 |
| Centers of Biomedical Research Excellence (COBRE) Phase III: Transitional Centers [P30] |
93.389 |
RFA-RR-09-005 |
| Minority-Based Community Clinical Oncology Program (U10) |
93.399 |
RFA-CA-09-023 |
| Renewal of Centers of Biomedical Research Excellence (COBRE)[P20] |
93.389 |
PAR-09-180 |
Search Results 10641-10680 of 14606
[Prev] 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312 313 314 315 316 317 318 319 320 321 322 323 324 325 326 327 328 329 330 331 332 333 334 335 336 337 338 339 340 341 342 343 344 345 346 347 348 349 350 351 352 353 354 355 356 357 358 359 360 361 362 363 364 365 366 [Next] |
